Starling Oncology, Inc. Debt Conversion, Converted Instrument, Amount
Starling Oncology, Inc. (DFPH) had Debt Conversion, Converted Instrument, Amount of $37.23 thousand as of 2025-03-24, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-05-07
- 2025-03-24: Debt Conversion, Converted Instrument, Amount $37.23K.
| Period end | Debt Conversion, Converted Instrument, Amount |
|---|---|
| 2025-03-24 | $37.23K 10-Q · filed 2026-05-07 |